Delivra Signs Exclusive Licensing Deal with ARA-Avanti Rx Analytics for Hemp Non-Psychoactive Cannabinoid, Terpene and Flavonoid Formulations and Products
TORONTO, ON–(Marketwired – May 10, 2017) – Delivra Corp. (TSX VENTURE: DVA) (“Delivra” or the “Company”) and ARA-Avanti Rx Analytics […]